Phase
Condition
Cancer Treatment
Cancer
Vaccines
Treatment
N/AClinical Study ID
Ages 18-75 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Advanced NSCLC diagnosed histologically; Expected survival ≥ 6 month;
Without Druggable molecular events (EGFR, ALK, c-Met, BRAF, Ret, etc)
ECOG / PS score: 0-2, and the main organ function to meet the following criteria: HB ≥ 90g / L, ANC ≥ 1.5 × 109 / L, PLT ≥ 80 × 109 / L,BIL <1.5 times the upper limit ofnormal (ULN); Liver ALT and AST <2.5 × ULN and if liver metastases, ALT and AST <5 ×ULN; Serum Cr ≤ 1 × ULN, endogenous creatinine clearance ≥50ml/min
Exclusion
Exclusion Criteria:
Patient can not comply with research program requirements or follow-up;
Patient will receive immunotherapy;
Study Design
Connect with a study center
Shanghai Changzheng Hospital
Shanghai, Shanghai 200003
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.